Covered recipient · General Payments record
ALEX S MIRAKIAN
Allopathic & Osteopathic Physicians Radiology Radiation Oncology
General Payments · PY2018–2024
$2,214.79
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $387.08 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $125.00 | 1 |
| Myriad Genetic Laboratories, Inc. | $83.48 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $70.30 | 1 |
| Novocure Inc. | $52.71 | 2 |
| Sumitomo Pharma America, Inc. | $41.32 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $125.00 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126678016 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $14.27 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086167022 | CMS |
| Myriad Genetic Laboratories, Inc. | $83.48 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152536507 | CMS |
| Novocure Inc. | $21.20 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123333628 | CMS |
| Novocure Inc. | $31.51 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123333630 | CMS |
| Sumitomo Pharma America, Inc. | $19.22 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148891695 | CMS |
| Sumitomo Pharma America, Inc. | $22.10 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148891697 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $70.30 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144963254 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.